Counseling Family Members and Monitoring for Evidence of Disease in Asymptomatic Carriers of Amyloid Transthyretin Cardiac Amyloidosis
Authors:
- 7 October 2022
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 185, S43-S50
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Guideline of transthyretin-related hereditary amyloidosis for cliniciansOrphanet Journal of Rare Diseases, 2013
- Green tea halts progression of cardiac transthyretin amyloidosis: an observational reportClinical Research in Cardiology, 2012
- Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy associated with transthyretin alanine 60 variantEuropean Heart Journal, 2011
- Significance of the amyloidogenic transthyretin Val 122 Ile allele in African Americans in the Arteriosclerosis Risk in Communities (ARIC) and Cardiovascular Health (CHS) StudiesAmerican Heart Journal, 2010
- TTR familial amyloid polyneuropathy: does a mitochondrial polymorphism entirely explain the parent-of-origin difference in penetrance?European Journal of Human Genetics, 2010
- Parent-of-origin effect in transthyretin related amyloid polyneuropathyAmyloid, 2009
- Heterogeneity of penetrance in familial amyloid polyneuropathy, ATTR Val30Met, in the Swedish populationAmyloid, 2008
- Transthyretin stability as a key factor in amyloidogenesis: X-ray analysis at atomic resolutionJournal of Molecular Biology, 2001
- Familial amyloid polyneuropathy (TTR ala 60) in north west Ireland: a clinical, genetic, and epidemiological study.Journal of Neurology, Neurosurgery & Psychiatry, 1995
- Familial Amyloidotic Polyneuropathy in Sweden: Geographical Distribution, Age of Onset, and PrevalenceHuman Heredity, 1993